BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36251143)

  • 1. Antihypertensive Use and the Risk of Alzheimer's Disease and Related Dementias among Older Adults in the USA.
    Pan X; Zhang D; Heo JH; Park C; Li G; Dengler-Crish CM; Li Y; Gu Y; Young HN; Lavender DL; Shi L
    Drugs Aging; 2022 Nov; 39(11):875-886. PubMed ID: 36251143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of combination statin and antihypertensive therapy with reduced Alzheimer's disease and related dementia risk.
    Barthold D; Joyce G; Diaz Brinton R; Wharton W; Kehoe PG; Zissimopoulos J
    PLoS One; 2020; 15(3):e0229541. PubMed ID: 32130251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Antihypertensive Medication Consumption and Drug-Drug Interaction with Statin and Metformin with Reduced Alzheimer's Disease and Related Dementias Risk among Hypertensive Patients with Mild Cognitive Impairment using High Volume Claims Data.
    Lundin SK; Hu X; Feng J; Lundin KK; Chen Y; Tao C
    Res Sq; 2023 Apr; ():. PubMed ID: 37090575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries.
    Marcum ZA; Gabriel N; Bress AP; Hernandez I
    JAMA Netw Open; 2023 Jan; 6(1):e2249370. PubMed ID: 36598787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Race/Ethnicity-Specific Changes in Antihypertensive Medication Classes Initiated Among Medicare Beneficiaries With the Eighth Joint National Committee Panel Member Report.
    Colvin CL; King JB; Oparil S; Wright JT; Ogedegbe G; Mohanty A; Hardy ST; Huang L; Hess R; Muntner P; Bress A
    JAMA Netw Open; 2020 Nov; 3(11):e2025127. PubMed ID: 33206191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network.
    Smith SM; Winterstein AG; Gurka MJ; Walsh MG; Keshwani S; Libby AM; Hogan WR; Pepine CJ; Cooper-DeHoff RM
    J Am Heart Assoc; 2023 Jan; 12(1):e026652. PubMed ID: 36565195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should ACE inhibitors or calcium channel blockers be used for post-transplant hypertension?
    Seeman T; Feber J
    Pediatr Nephrol; 2021 Mar; 36(3):539-549. PubMed ID: 32060819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System.
    An J; Wei R; Zhou H; Luong TQ; Gould MK; Mefford MT; Harrison TN; Creekmur B; Lee MS; Sim JJ; Brettler JW; Martin JP; Ong-Su AL; Reynolds K
    J Am Heart Assoc; 2021 Feb; 10(3):e019669. PubMed ID: 33307964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel blockers for people with chronic kidney disease requiring dialysis.
    Mugendi GA; Mutua FM; Natale P; Esterhuizen TM; Strippoli GF
    Cochrane Database Syst Rev; 2020 Oct; 10(10):CD011064. PubMed ID: 33000470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ecology of Antihypertensives in the United States, 1997-2017.
    Johansen ME; Niforatos JD; Sussman JB
    J Gen Intern Med; 2021 Mar; 36(3):699-704. PubMed ID: 32968967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of antihypertensive treatment using real-world Japanese data-the retrospective study of antihypertensives for lowering blood pressure (REAL) study.
    Ohishi M; Yoshida T; Oh A; Hiroi S; Takeshima T; Otsuka Y; Iwasaki K; Shimasaki Y
    Hypertens Res; 2019 Jul; 42(7):1057-1067. PubMed ID: 30842611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Angiotensin Receptor Blocker Therapy and Incidence of Epilepsy in Patients With Hypertension.
    Doege C; Luedde M; Kostev K
    JAMA Neurol; 2022 Dec; 79(12):1296-1302. PubMed ID: 36251288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monotherapy With Major Antihypertensive Drug Classes and Risk of Hospital Admissions for Mood Disorders.
    Boal AH; Smith DJ; McCallum L; Muir S; Touyz RM; Dominiczak AF; Padmanabhan S
    Hypertension; 2016 Nov; 68(5):1132-1138. PubMed ID: 27733585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-blockers for hypertension.
    Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
    Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis.
    Pongpanich P; Pitakpaiboonkul P; Takkavatakarn K; Praditpornsilpa K; Eiam-Ong S; Susantitaphong P
    Int Urol Nephrol; 2018 Dec; 50(12):2261-2278. PubMed ID: 30324578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of calcium channel blockers in the prevention of stroke in adults with hypertension: a meta-analysis of data from 273,543 participants in 31 randomized controlled trials.
    Chen GJ; Yang MS
    PLoS One; 2013; 8(3):e57854. PubMed ID: 23483932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.